Innovation
Researchers at the Del Monte Institute for Neuroscience at the University of Rochester in New York are investigating a potential biomarker in the brain that could diagnose psychosis before symptoms appear.
Hearts have a special meaning for Heavenleigh Weilage. For one thing, she was born on Valentine’s Day 2022. For another, she was the first child in the country to receive a pacemaker so small it’s the size of a large pill.
Sanford Health, America’s largest rural health system, is revolutionizing care delivery with telemedicine and AI. In this conversation, Dave Newman, M.D., vice president and chief medical officer for virtual care at Sanford Health, discusses how innovative virtual care models and AI-powered…
University of California Davis Health has launched a first-in-the-nation program called PATH (Promoting Accessibility To Healthcare) to improve the health care experience for children who have autism and other neurodevelopmental disabilities.
Modern medical technology has led to remarkable advancements, but staff at Loma Linda University Medical Center-Murrieta know that something as basic as a strategically labeled bracelet can help save a life.
In this conversation, Mindy Estes, M.D., former CEO of Saint Luke's Health System and former AHA board chair, and Tori Bayless, CEO of Luminis Health and AHA board member, discuss how hospital leaders and boards can drive meaningful change, the impact of data-driven decision making, and the…
In this conversation, Carlos Roberts, M.D., urogynecologist and vice president and chief medical officer of the Women and Children Service Line at WellSpan Health, discusses the organization's commitment to zero harm, its innovative tier structure for daily safety huddles, and its fostered culture…
For 2025, a rebound may be in store for investments in digital health startups, according to a recent survey report from Summit Health Advisors.
A clinical trial at Memorial Sloan Kettering Cancer Center in New York City has achieved groundbreaking results in treating rectal cancer using the immunotherapy drug Jemperli.
At the University of Washington Medicine in Seattle, researchers are leveraging machine learning — a subset of artificial intelligence — and synthetic proteins to counteract the damaging effects of a snake bite.